Trends of medicare reimbursement for breast cancer and reconstructive surgery.
J Plast Reconstr Aesthet Surg
; 94: 50-53, 2024 Jul.
Article
en En
| MEDLINE
| ID: mdl-38759511
ABSTRACT
This study evaluated trends in Medicare reimbursement for commonly performed breast oncologic and reconstructive procedures. Average national relative value units (RVUs) for physician-based work, facilities, and malpractice were collected along with the corresponding conversion factors for each year. From 2010 to 2021, there was an overall average decrease of 15% in Medicare reimbursement for both breast oncology (-11%) and reconstructive procedures (-16%). Based on these findings, breast and reconstructive surgeons should advocate for reimbursement that better reflects the costs of their practice.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
/
Medicare
/
Mamoplastia
Límite:
Female
/
Humans
País como asunto:
America do norte
Idioma:
En
Año:
2024
Tipo del documento:
Article